Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Discovery of a novel series of quinoxalines as inhibitors of c-Met kinaseJohn Porter, Simon Lumb, Fabien Lecomte, et al.Journal of Molecular Biology|February 21, 2021
Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational EquilibriumGeorge R Nahass, Yuanzi Sun, Yong Xu, et al.Communications Biology|July 31, 2020
Structural effects of the highly protective V127 polymorphism on human prion proteinLaszlo L P Hosszu, Rebecca Conners, Daljit Sangar, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2008
4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinaseRikki Alexander, Ahrani Balasundaram, Mark Batchelor, et al.Bioorganic & Medicinal Chemistry Letters|April 17, 2009
Discovery of 4-azaindoles as novel inhibitors of c-Met kinaseJohn Porter, Simon Lumb, Richard J Franklin, et al.The Journal of Biological Chemistry|July 31, 2014
N-terminal domain of prion protein directs its oligomeric associationClare R Trevitt, Laszlo L P Hosszu, Mark Batchelor, et al.Molecular Pharmacology|August 24, 2004
A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft modelsStuart Emanuel, Robert H Gruninger, Angel Fuentes-Pesquera, et al.Open Biology|December 4, 2015
A systematic investigation of production of synthetic prions from recombinant prion proteinChristian Schmidt, Jeremie Fizet, Francesca Properzi, et al.Brain : a Journal of Neurology|March 28, 2023
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion diseaseTze How Mok, Akin Nihat, Nour Majbour, et al.Pageof 2